Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with cervical spondylotic radiculopathy (a type of neck condition caused by nerve compression) and have no other related complications
- You are between 18 and 65 years old (any gender)
- You have not received any treatment for your neck condition in the past month
- You have never had surgery for your neck condition
- You are able and willing to follow the study requirements consistently
- You are in good mental health and have no history of mental illness
- You are willing to give your informed consent and sign the consent form
Who may not be able to join:
- You do not have a confirmed diagnosis of the specific neck condition this trial is studying
- You are currently pregnant
- You have severe narrowing of the openings in the spine where nerves pass through (confirm with trial site)
- You have osteoporosis along with a spinal tumour or a bone infection
- You have an infectious disease, skin wounds or damage in the treatment area, or known allergies (confirm with trial site)
- You have serious problems with your heart, lungs, or other major organs
- You are unable or unwilling to cooperate with the study team and its requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Visual analogue scale; Range of motion; Muscle strength
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.